TA, E., S, M., TP, B., JR, H., D, M., WJ, P., . . . JA, C. (2005). The development of potent and selective bisarylmaleimide GSK3 inhibitors. Bioorganic & medicinal chemistry letters, 15(4), 899. https://doi.org/10.1016/j.bmcl.2004.12.063
Chicago Style (17th ed.) CitationTA, Engler, et al. "The Development of Potent and Selective Bisarylmaleimide GSK3 Inhibitors." Bioorganic & Medicinal Chemistry Letters 15, no. 4 (2005): 899. https://doi.org/10.1016/j.bmcl.2004.12.063.
MLA (9th ed.) CitationTA, Engler, et al. "The Development of Potent and Selective Bisarylmaleimide GSK3 Inhibitors." Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 4, 2005, p. 899, https://doi.org/10.1016/j.bmcl.2004.12.063.
Warning: These citations may not always be 100% accurate.